Home

Aerovate Therapeutics, Inc. - Common Stock (AVTE)

2.6000
-0.0200 (-0.76%)

Aerovate Therapeutics Inc is a biotechnology company focused on developing innovative therapies for patients with serious respiratory diseases

The company's research is centered around creating novel treatments that target rare and debilitating conditions affecting lung function. By leveraging cutting-edge science and technology, Aerovate aims to improve patient outcomes and enhance quality of life for those suffering from these challenging medical conditions. Through its commitment to advancing respiratory therapeutic options, Aerovate is positioned to make a significant impact within the healthcare landscape.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Aerovate Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aerovate Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aerovate Therapeutics, Inc. - Common Stock trade on?
Aerovate Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aerovate Therapeutics, Inc. - Common Stock?
The ticker symbol for Aerovate Therapeutics, Inc. - Common Stock is AVTE on the Nasdaq Stock Market
What is the current price of Aerovate Therapeutics, Inc. - Common Stock?
The current price of Aerovate Therapeutics, Inc. - Common Stock is 2.600
When was Aerovate Therapeutics, Inc. - Common Stock last traded?
The last trade of Aerovate Therapeutics, Inc. - Common Stock was at 12:45 pm EST on January 31st, 2025